Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Passage BIO, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 46 | 42 | −4 |
| Shares | 37.6M | 36.3M | −1.31M (−3.5%) |
| Value | $21.6M | $12.8M | −$8.75M (−40.6%) |
New holders (2)
Institutions that held Passage BIO, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 45,402 | $16.0K | 0.00% |
| Mariner, LLC | 11,934 | $4.21K | 0.00% |
Sold out (6)
Institutions that held Passage BIO, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Jane Street Group, LLC | 78,190 | $44.3K |
| Ground Swell Capital, LLC | 25,424 | $14.4K |
| FMR LLC | 21,054 | $11.9K |
| HRT Financial LP | 13,850 | $7.00K |
| Virtu Financial LLC | 10,286 | $6.00K |
| Atria Wealth Solutions, Inc. | 10,000 | $5.67K |